BIOMAT Database Logo BIOMAT Database Logo

[Vasovagal syncope]. 1997

E Nellessen, and P Melon, and H Kulbertus
Service de Cardiologie, Université de Liège.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D001795 Blood Pressure Determination Techniques used for measuring BLOOD PRESSURE. Blood Pressure Determinations,Determination, Blood Pressure
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D018667 Tilt-Table Test A standard and widely accepted diagnostic test used to identify patients who have a vasodepressive and/or cardioinhibitory response as a cause of syncope. (From Braunwald, Heart Disease, 7th ed) Test, Tilt-Table,Tilt Table Test
D019462 Syncope, Vasovagal Loss of consciousness due to a reduction in blood pressure that is associated with an increase in vagal tone and peripheral vasodilation. Syncope, Neurocardiogenic,Syncope, Neurogenic,Syncope, Vasodepressor,Neurally Mediated Faint,Syncope, Cerebral,Syncope, Malignant Neurocardiogenic,Syncope, Supine,Syncope, Vasovagal, Neurally-Mediated,Cerebral Syncope,Cerebral Syncopes,Faint, Neurally Mediated,Faints, Neurally Mediated,Malignant Neurocardiogenic Syncope,Malignant Neurocardiogenic Syncopes,Neurally Mediated Faints,Neurocardiogenic Syncope,Neurocardiogenic Syncope, Malignant,Neurocardiogenic Syncopes,Neurocardiogenic Syncopes, Malignant,Neurogenic Syncope,Neurogenic Syncopes,Supine Syncope,Supine Syncopes,Syncopes, Cerebral,Syncopes, Malignant Neurocardiogenic,Syncopes, Neurocardiogenic,Syncopes, Neurogenic,Syncopes, Supine,Syncopes, Vasodepressor,Syncopes, Vasovagal,Vasodepressor Syncope,Vasodepressor Syncopes,Vasovagal Syncope,Vasovagal Syncopes

Related Publications

E Nellessen, and P Melon, and H Kulbertus
Vasovagal syncope.
June 1989, Critical care nurse,
E Nellessen, and P Melon, and H Kulbertus
Vasovagal syncope.
July 2003, Nursing,
E Nellessen, and P Melon, and H Kulbertus
Vasovagal syncope.
November 2000, Annals of internal medicine,
E Nellessen, and P Melon, and H Kulbertus
"Vasovagal" syncope.
October 1976, British medical journal,
E Nellessen, and P Melon, and H Kulbertus
Vasovagal Syncope.
June 2021, JAMA internal medicine,
E Nellessen, and P Melon, and H Kulbertus
[Vasovagal syncope].
November 2008, Annales de dermatologie et de venereologie,
E Nellessen, and P Melon, and H Kulbertus
Vasovagal syncope.
August 1968, The Journal of the Dental Association of South Africa = Die Tydskrif van die Tandheelkundige Vereniging van Suid-Afrika,
E Nellessen, and P Melon, and H Kulbertus
[Vasovagal syncope].
June 1993, Recenti progressi in medicina,
E Nellessen, and P Melon, and H Kulbertus
Vasovagal syncope.
April 1986, Lancet (London, England),
E Nellessen, and P Melon, and H Kulbertus
Vasovagal syncope?
March 1986, Lancet (London, England),
Copied contents to your clipboard!